Hologic's breast-biopsy device gets CE Mark approval

11/6/2008 | HealthImaging.com

Hologic has secured European CE Mark approval for its Celero vacuum-assisted core biopsy device. The product is designed to reach lesions in the axilla, as well as other parts of the breast, during ultrasound imaging. Hologic also obtained clearance in Europe for other products, including the CeleroMark and CeleroMark-2S biopsy site identifiers.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Executive Medical Director
Aspirus Network Inc
Wausau, WI